Congress has a date circled on the calendar: Dec. 11, the point at which a farm bill provision tied to hemp-derived intoxicants is set to close. What happens before then could determine whether
A federal ban on intoxicating hemp products now takes effect Dec. 11, not Nov. 12 as originally scheduled, after Congress tucked a short delay into last month's government-funding bill. That gives an
A decade after Georgia legalized medical cannabis, the program's expansion remains stuck in committee, and one licensed operator decided lobbying from the sidelines wasn't working. Fine Fettle, one
Two senators from opposite sides of the aisle have filed legislation meant to solve a problem that has quietly plagued cannabis retailers for years: getting basic insurance coverage without an
Two Michigan cannabis retailers put their marketing budget toward a public art commission this week, and the result says something about how dispensary brands are learning to spend outside the usual
Nevada City is quietly positioning itself as one of the more permissive small jurisdictions in its region on cannabis policy, and the shift is happening through ordinary municipal process rather than
Baby Boomers are quietly turning into one of the more interesting demand pockets in the cannabis business, and Michigan's oversupplied market has real reason to pay attention. National survey data
Cannabis retailers in Maine are under increasing pressure to keep inventory records airtight, and the state's seed-to-sale tracking infrastructure has become the backbone of that effort. Regulators
The federal law that redefines hemp is already on the books, signed in November 2025, and it is not going away regardless of what happens next in Congress. What remains genuinely unsettled is the
TSRgrow has rolled out a significant expansion of GROWHub, its cultivation software platform, adding energy monitoring, expanded batch-record tools, Metrc integration and building management system
Money is flowing into cannabis equities at a pace the sector hasn't seen in years, and the AdvisorShares Pure US Cannabis ETF (MSOS) is the clearest gauge of it. The fund posted a one-year net asset
Health In Tech, Inc. (NASDAQ: HIT) is drawing a mixed but active round of coverage from Wall Street research desks, with Maxim Group reaffirming a "Buy" rating and a $3.00 price target even as its
A federal judge in Virginia spent nearly five hours Wednesday hearing arguments over whether to pause enforcement of the state's sweeping new hemp restrictions before they take effect Saturday. Seven
